SAN DIEGO, Sept. 2, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced the appointments of Kazuko Matsuda, M.D., Ph.D, MPH as Chief Medical Officer and Michael Gennaro CPA, MBA as Chief Financial Officer.
